Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

The RimL transacetylase provides resistance to translation inhibitor microcin C.

Kazakov T, Kuznedelov K, Semenova E, Mukhamedyarov D, Datsenko KA, Metlitskaya A, Vondenhoff GH, Tikhonov A, Agarwal V, Nair S, Van Aerschot A, Severinov K.

J Bacteriol. 2014 Oct;196(19):3377-85. doi: 10.1128/JB.01584-14. Epub 2014 Jul 7.

2.

N-alkylated aminoacyl sulfamoyladenosines as potential inhibitors of aminoacylation reactions and microcin C analogues containing D-amino acids.

Vondenhoff GH, Pugach K, Gadakh B, Carlier L, Rozenski J, Froeyen M, Severinov K, Van Aerschot A.

PLoS One. 2013 Nov 4;8(11):e79234. doi: 10.1371/journal.pone.0079234. eCollection 2013.

3.

Microcin C and albomycin analogues with aryl-tetrazole substituents as nucleobase isosters are selective inhibitors of bacterial aminoacyl tRNA synthetases but lack efficient uptake.

Vondenhoff GH, Gadakh B, Severinov K, Van Aerschot A.

Chembiochem. 2012 Sep 3;13(13):1959-69. doi: 10.1002/cbic.201200174. Epub 2012 Jul 30.

PMID:
22847961
4.

Aminoacyl-tRNA synthetase inhibitors as potential antibiotics.

Vondenhoff GH, Van Aerschot A.

Eur J Med Chem. 2011 Nov;46(11):5227-36. doi: 10.1016/j.ejmech.2011.08.049. Epub 2011 Sep 16. Review.

PMID:
21968372
5.

Microcin C: biosynthesis, mode of action, and potential as a lead in antibiotics development.

Vondenhoff GH, Van Aerschot A.

Nucleosides Nucleotides Nucleic Acids. 2011 Jul-Aug;30(7-8):465-74. doi: 10.1080/15257770.2011.583972.

PMID:
21888539
6.

Extended targeting potential and improved synthesis of Microcin C analogs as antibacterials.

Vondenhoff GH, Dubiley S, Severinov K, Lescrinier E, Rozenski J, Van Aerschot A.

Bioorg Med Chem. 2011 Sep 15;19(18):5462-7. doi: 10.1016/j.bmc.2011.07.052. Epub 2011 Aug 3.

PMID:
21855353
7.

Characterization of peptide chain length and constituency requirements for YejABEF-mediated uptake of microcin C analogues.

Vondenhoff GH, Blanchaert B, Geboers S, Kazakov T, Datsenko KA, Wanner BL, Rozenski J, Severinov K, Van Aerschot A.

J Bacteriol. 2011 Jul;193(14):3618-23. doi: 10.1128/JB.00172-11. Epub 2011 May 20.

8.

MccE provides resistance to protein synthesis inhibitor microcin C by acetylating the processed form of the antibiotic.

Novikova M, Kazakov T, Vondenhoff GH, Semenova E, Rozenski J, Metlytskaya A, Zukher I, Tikhonov A, Van Aerschot A, Severinov K.

J Biol Chem. 2010 Apr 23;285(17):12662-9. doi: 10.1074/jbc.M109.080192. Epub 2010 Feb 16.

9.

Synthetic microcin C analogs targeting different aminoacyl-tRNA synthetases.

Van de Vijver P, Vondenhoff GH, Kazakov TS, Semenova E, Kuznedelov K, Metlitskaya A, Van Aerschot A, Severinov K.

J Bacteriol. 2009 Oct;191(20):6273-80. doi: 10.1128/JB.00829-09. Epub 2009 Aug 14.

10.

Maturation of the translation inhibitor microcin C.

Metlitskaya A, Kazakov T, Vondenhoff GH, Novikova M, Shashkov A, Zatsepin T, Semenova E, Zaitseva N, Ramensky V, Van Aerschot A, Severinov K.

J Bacteriol. 2009 Apr;191(7):2380-7. doi: 10.1128/JB.00999-08. Epub 2009 Jan 23.

11.

Antibacterial 5'-O-(N-dipeptidyl)-sulfamoyladenosines.

Van de Vijver P, Vondenhoff GH, Denivelle S, Rozenski J, Verhaegen J, Van Aerschot A, Herdewijn P.

Bioorg Med Chem. 2009 Jan 1;17(1):260-9. doi: 10.1016/j.bmc.2008.11.054. Epub 2008 Nov 27.

PMID:
19070499
12.

Escherichia coli peptidase A, B, or N can process translation inhibitor microcin C.

Kazakov T, Vondenhoff GH, Datsenko KA, Novikova M, Metlitskaya A, Wanner BL, Severinov K.

J Bacteriol. 2008 Apr;190(7):2607-10. doi: 10.1128/JB.01956-07. Epub 2008 Jan 25.

Supplemental Content

Loading ...
Support Center